Disruptive Pharma AB (publ) (STO:DPHA)

Market Cap	54.40M
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	44.59M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	140,974
Open	1.210
Previous Close	1.220
Day's Range	1.108 - 1.230
52-Week Range	0.881 - 27.000
Beta	-0.20
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Disruptive Pharma AB

Disruptive Pharma AB (publ) operates as a pharmaceutical technology company in Sweden. The company develops and commercializes Formulite, a patented and clinically evaluated platform technology for oral drug formulation and drug product development. The company is based in Stockholm, Sweden.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2021
• Country: Sweden
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: DPHA

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 5, 2026

Data Sources Report a data error